Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
05 01 2021
Historique:
pubmed: 10 11 2020
medline: 12 1 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

The aim of the study was to document cardiovascular clinical findings, cardiac imaging, and laboratory markers in children presenting with the novel multisystem inflammatory syndrome associated with coronavirus disease 2019 (COVID-19) infection. This real-time internet-based survey has been endorsed by the Association for European Paediatric and Congenital Cardiologists Working Groups for Cardiac Imaging and Cardiovascular Intensive Care. Children 0 to 18 years of age admitted to a hospital between February 1 and June 6, 2020, with a diagnosis of an inflammatory syndrome and acute cardiovascular complications were included. A total of 286 children from 55 centers in 17 European countries were included. The median age was 8.4 years (interquartile range, 3.8-12.4 years) and 67% were boys. The most common cardiovascular complications were shock, cardiac arrhythmias, pericardial effusion, and coronary artery dilatation. Reduced left ventricular ejection fraction was present in over half of the patients, and a vast majority of children had raised cardiac troponin when checked. The biochemical markers of inflammation were raised in most patients on admission: elevated C-reactive protein, serum ferritin, procalcitonin, N-terminal pro B-type natriuretic peptide, interleukin-6 level, and D-dimers. There was a statistically significant correlation between degree of elevation in cardiac and biochemical parameters and the need for intensive care support ( Cardiac involvement is common in children with multisystem inflammatory syndrome associated with the Covid-19 pandemic. The majority of children have significantly raised levels of N-terminal pro B-type natriuretic peptide, ferritin, D-dimers, and cardiac troponin in addition to high C-reactive protein and procalcitonin levels. In comparison with adults with COVID-19, mortality in children with multisystem inflammatory syndrome associated with COVID-19 is uncommon despite multisystem involvement, very elevated inflammatory markers, and the need for intensive care support.

Sections du résumé

BACKGROUND
The aim of the study was to document cardiovascular clinical findings, cardiac imaging, and laboratory markers in children presenting with the novel multisystem inflammatory syndrome associated with coronavirus disease 2019 (COVID-19) infection.
METHODS
This real-time internet-based survey has been endorsed by the Association for European Paediatric and Congenital Cardiologists Working Groups for Cardiac Imaging and Cardiovascular Intensive Care. Children 0 to 18 years of age admitted to a hospital between February 1 and June 6, 2020, with a diagnosis of an inflammatory syndrome and acute cardiovascular complications were included.
RESULTS
A total of 286 children from 55 centers in 17 European countries were included. The median age was 8.4 years (interquartile range, 3.8-12.4 years) and 67% were boys. The most common cardiovascular complications were shock, cardiac arrhythmias, pericardial effusion, and coronary artery dilatation. Reduced left ventricular ejection fraction was present in over half of the patients, and a vast majority of children had raised cardiac troponin when checked. The biochemical markers of inflammation were raised in most patients on admission: elevated C-reactive protein, serum ferritin, procalcitonin, N-terminal pro B-type natriuretic peptide, interleukin-6 level, and D-dimers. There was a statistically significant correlation between degree of elevation in cardiac and biochemical parameters and the need for intensive care support (
CONCLUSIONS
Cardiac involvement is common in children with multisystem inflammatory syndrome associated with the Covid-19 pandemic. The majority of children have significantly raised levels of N-terminal pro B-type natriuretic peptide, ferritin, D-dimers, and cardiac troponin in addition to high C-reactive protein and procalcitonin levels. In comparison with adults with COVID-19, mortality in children with multisystem inflammatory syndrome associated with COVID-19 is uncommon despite multisystem involvement, very elevated inflammatory markers, and the need for intensive care support.

Identifiants

pubmed: 33166189
doi: 10.1161/CIRCULATIONAHA.120.050065
doi:

Substances chimiques

Antibodies, Viral 0
Biomarkers 0
Fibrin Fibrinogen Degradation Products 0
IL6 protein, human 0
Immunoglobulin G 0
Immunoglobulin M 0
Interleukin-6 0
Peptide Fragments 0
fibrin fragment D 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0
C-Reactive Protein 9007-41-4
Ferritins 9007-73-2

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-32

Investigateurs

Xavier Iriart (X)
Jelena Hubrechts (J)
Irene Mariette Kuipers (IM)
Ana R Sousa (AR)
Andrea Donti (A)
Abigail Sharpe (A)
Zdenka Reinhardt (Z)
Francesca Cairello (F)
Daniel De Wolf (D)
Marisa Vieira (M)
Cecilia Lazea (C)
Ferran Gran (F)
Constancio Medrano-Lopez (C)
Almudena Ortiz-Garrido (A)
Vladislav Vukomanovic (V)
Bernadette Elisabeth Brent (BE)
Ornella Milanesi (O)
Wendy Dewals (W)
Begoña Manso (B)
Emanuela Valsangiacomo-Buchel (E)
Andreia Francisco (A)
Marie-Christine Seghaye (MC)
Isabelle Loeckx (I)
Moises Rodriguez-Gonzalez (M)
Susana Maria ReyGarcía (SM)
Victoria C Ziesenitz (VC)
Giulia Bordin (G)
Gabriela Doros (G)
Gernot Grangl (G)
Shalan Uaid Fadl (SU)
Karl Viktor Perminow (KV)
Fernando Centeno (F)
Fatima Pinto (F)
Jussi Niemelä (J)
Hari Krishnan Kanthimathinathan (HK)
Paula Cecilia Randanne (PC)
Cezary Niszczota (C)
Gian Vincenzo Zuccotti (GV)
Inés Leoz Gordillo (IL)
Madhu Obeyasekhara (M)
Catherine Armstrong (C)
Karina Butler (K)
Matteo Ciuffreda (M)
Anna Maria Villar (AM)
Naga Pappula (N)
Roberta Caorsi (R)
Davinder Singh (D)
Saravanan Durairaj (S)
Karen McLeod (K)
Giulio Calcagni (G)
Youssef Quizad (Y)
Marc Gewillig (M)
Taco Willem Kuijpers (TW)
Rita Ataide (R)
Marianna Fabi (M)
Tara Bharucha (T)
Khushnood Abbas (K)
Silvia Alessandra Magrass (SA)
James Wong (J)
Daniela Iacob (D)
Joan Balcells (J)
Nuria GilVillanueva (N)
Victorio Cuenca-Peiro (V)
Ivana Cerovi (I)
Avishay Sarfatt (A)
Mahmoud Zaqout (M)
Elia Sanchez-Valderrabanos (E)
Janet Kelly-Geyer (J)
Faim Diogo (F)
Nathalie Cajgfinger (N)
Mascart Françoise (M)
Fernando Rueda-Nuñez (F)
Matthias Gorenflo (M)
Alessandra Grison (A)
Delia Mihailov (D)
Martin Koestenberger (M)
Carlos Alcalde (C)
Conceiçao Trigo (C)
Anita Arola (A)
Katarina Hanseus (K)

Auteurs

Israel Valverde (I)

Department of Pediatric Cardiology and Pediatric Intensive Care, Hospital Infantil Virgen del Rocio, Institute of Biomedicine IBIS, CIBER-CV, Seville, Spain (I.V.).

Yogen Singh (Y)

Department of Pediatrics - Pediatric Cardiology / Neonatology, Cambridge University Hospitals and University of Cambridge School of Clinical Medicine, UK (Y.S.).

Joan Sanchez-de-Toledo (J)

Department of Cardiology, Hospital Sant Joan de Deu, Barcelona, Spain (J.S.-d.-T.).

Paraskevi Theocharis (P)

Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, UK (I.V., P.T., O.M.).

Ashish Chikermane (A)

Birmingham Children's Hospital, UK (A.C.).

Sylvie Di Filippo (S)

Department of Paediatric Cardiology and Paediatric Intensive Care Unit, University of Lyon Medical Center, France (S.D.F.).

Beata Kuciñska (B)

Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Poland (B.K.).

Savina Mannarino (S)

Hospital Vittore Buzzi-Asst Fbf Sacco, Milano, Italy (S.M.).

Amalia Tamariz-Martel (A)

Department of Paediatric Cardiology and Paediatric Intensive Care Unit, Hospital Infantil Universitario Niño Jesus, Madrid, Spain (A.T.-M.).

Federico Gutierrez-Larraya (F)

Department of Paediatric Cardiology, Hospital La Paz, Madrid, Spain (F.G.-L.).

Giridhar Soda (G)

Paediatric Cardiology, Royal Manchester Childrens Hospital, UK (G.S.).

Kristof Vandekerckhove (K)

Department of Paediatric Cardiology. Ghent University Hospital, Belgium (K.V.).

Francisco Gonzalez-Barlatay (F)

Department of Paediatric Cardiology, Bristol Royal Hospital for Children, University Hospitals Bristol and Weston NHS Foundation Trust, UK (F.G.B.).

Colin Joseph McMahon (CJ)

Department of Paediatric Cardiology and Paediatric Infectious Disease, CHI, Crumlin, Dublin, Ireland (C.J.M.).

Simona Marcora (S)

Department of Pediatric Cardiology, Papa Giovanni XXIII Hospital, Bergamo, Italy (S.A.M.).

Carlo Pace Napoleone (CP)

Pediatric Cardiac Surgery, Regina Margherita Children's Hospital, Torino, Italy (C.P.N.).

Phuoc Duong (P)

Department of Paediatric Cardiology and Paediatric Intensive Care Unit, Alder Hey Children's Hospital Liverpool, UK (P.D.).

Giulia Tuo (G)

Paediatric Cardiology and Pediatric Rheumatology Clinic, IRCCS Giannina Gaslini Institute, Genoa, Italy (G.T.).

Antigoni Deri (A)

Department of Paediatric Cardiology and Paediatric Intensive Care Unit, Leeds Children's Hospital, UK (A.D.).

Gauri Nepali (G)

Department of Paediatric Cardiology, East Midland Congenital heart Centre, Glenfield Hospital, Leicester, UK (G.N.).

Maria Ilina (M)

Department of Paediatric Cardiology, Royal Hospital for Children, Glasgow, UK (M.I.).

Paolo Ciliberti (P)

Pediatric Cardiology and Cardiac Surgery Department, Bambino Gesù Children's Hospital IRCSS, Rome, Italy (P.C.).

Owen Miller (O)

School of Biomedical Engineering & Imaging Sciences and Department of Women and Children's Health, Faculty of Life Science and Medicine, King's College London, King's Health Partners, St Thomas' Hospital, UK (I.V., O.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH